Vietnam Veterans Liver Fluke Cancer Study Act

119th Congress Introduced by Juan Ciscomani and 8 co-sponsors

HR 586 mandates a study on liver fluke infections and liver cancer among Vietnam veterans, aiming to improve health outcomes and inform healthcare for affected individuals.

Received in the Senate and Read twice and referred to the Committee on Veterans' Affairs.

Purpose and Intent

The Vietnam Veterans Liver Fluke Cancer Study Act (HR 586) aims to address the health impacts of liver fluke infections among Vietnam veterans. The bill seeks to initiate a comprehensive study to investigate the potential link between liver fluke infections and the incidence of liver cancer in this population. This legislation acknowledges the unique health challenges faced by veterans who served in Vietnam, particularly regarding parasitic infections that may have long-term health consequences.

Key Provisions

Study Authorization: The bill mandates the Department of Veterans Affairs (VA) to conduct a study focused on the correlation between liver fluke infections and liver cancer among Vietnam veterans.

Data Collection: The study will involve collecting data on the prevalence of liver fluke infections and the rates of liver cancer diagnoses in veterans who served in Vietnam.

Reporting Requirements: The VA is required to report the findings of the study to Congress, providing insights into the health risks associated with liver fluke infections and recommendations for veterans' health care.

Affected Parties

Vietnam Veterans: The primary beneficiaries of this study are Vietnam veterans who may be at risk for liver fluke infections and related health issues.

Healthcare Providers: The findings could inform healthcare providers about the potential risks and necessary screenings for liver cancer in this demographic.

Veterans' Affairs: The VA will play a crucial role in conducting the study and implementing any necessary changes to health care policies based on the findings.

Legislative Timeline

Introduced: January 21, 2025

House Actions:

The bill was referred to the House Committee on Veterans' Affairs upon introduction.
It was subsequently referred to the Subcommittee on Health on February 25, 2025.
On April 7, 2025, the bill was passed in the House with overwhelming support (411-0) after a motion to suspend the rules.

Senate Actions:

On April 8, 2025, the bill was received in the Senate, read twice, and referred to the Committee on Veterans' Affairs for further consideration.

Conclusion

HR 586 represents a significant step towards understanding and addressing the health risks faced by Vietnam veterans due to liver fluke infections. By mandating a study, the bill aims to provide critical data that could lead to improved health outcomes and targeted interventions for affected veterans. The overwhelming support in the House indicates a strong commitment to addressing veterans' health issues.

Bill